Panagora Asset Management Inc V Tv Therapeutics Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$1.97 - $2.89 $1,028 - $1,508	-522 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.7 - $2.98 $887 - $1,555	522 New	522 $1,000
Q1 2019 May 15, 2019	SELL	$1.67 - $3.12 $49,943 - $93,306	-29,906 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.78 - $3.74 $12,523 - $60,049	-16,056 Reduced 34.93%	29,906 $79,000
Q3 2018 Nov 13, 2018	BUY	$0.7 - $1.58 $32,173 - $72,619	45,962 New	45,962 $35,000

Q2 2018 Aug 14, 2018	SELL	$0.71 - $4.04 $3,450 - $19,634	-4,860 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.91 - $7.83 $1,004 - $2,012	-257 Reduced 5.02%	4,860 $20,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $7.77 $19,956 - $39,759	5,117	5,117 $31,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.